BioSpace News Archive

Amedisys, Inc. reported its financial results for the three month period and year ended December 31, 2019.

Retrotope announced that the U.S. Food and Drug Administration Office of Orphan Products Development granted orphan drug designation for its chemically-modified polyunsaturated fatty acid drug for the treatment of Progressive SupraNuclear Palsy.

Personalis, Inc., a leader in advanced genomics for cancer, announced that the company will present at the Biomarkers Series UK 2020 conference in Manchester, UK, February 19-20.

First conditional approval of ZYNTEGLOTM (autologous CD34+ cells encoding βA-T87Q-globin gene) gene therapy for patients 12 years and older with transfusion-dependent β-thalassemia who do not have β0/β0 genotype in Europe achieved in 2019; Germany launch underway

Agilent Technologies Inc. reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year.

Cerner Corporation announced the appointment of Don Trigg to President and John Peterzalek to Chief Client and Services Officer.

Combining Leading Genetics Library With Proprietary, Commercial Scale Propagation Technology Sets Stage for Fundamental Changes in Hemp and Cannabis Markets

Vanda Pharmaceuticals Inc. announced it will release results for the fourth quarter and full year 2019 on Tuesday, February 25, 2020, after the market closes.

ENGLEWOOD, Colo., Feb. 18, 2020 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces today that it will host the Company’s 2019 full year and fourth quarter investor webcas

Newton Dentistry is one of a handful of dental offices in the state of Massachusetts to offer comprehensive dental implants in one location.